Credit Suisse’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $765K | Buy |
24,016
+1,690
| +8% | +$53.8K | ﹤0.01% | 2420 |
|
|
2023
Q4 | $452K | Sell |
22,326
-3,418
| -13% | -$69.2K | ﹤0.01% | 2770 |
|
|
2023
Q3 | $328K | Sell |
25,744
-8,873
| -26% | -$113K | ﹤0.01% | 2891 |
|
|
2023
Q2 | $626K | Buy |
34,617
+21,152
| +157% | +$382K | ﹤0.01% | 2650 |
|
|
2023
Q1 | $231K | Buy |
13,465
+13,464
| +1,346,400% | +$231K | ﹤0.01% | 3062 |
|
|
2022
Q4 | $22 | Sell |
1
-17,547
| -100% | -$386K | ﹤0.01% | 3645 |
|
|
2022
Q3 | $141K | Buy |
17,548
+140
| +0.8% | +$1.13K | ﹤0.01% | 3328 |
|
|
2022
Q2 | $122K | Sell |
17,408
-1,242
| -7% | -$8.7K | ﹤0.01% | 3478 |
|
|
2022
Q1 | $282K | Buy |
18,650
+3,682
| +25% | +$55.7K | ﹤0.01% | 3232 |
|
|
2021
Q4 | $329K | Buy |
14,968
+6,023
| +67% | +$132K | ﹤0.01% | 3265 |
|
|
2021
Q3 | $241K | Buy |
+8,945
| New | +$241K | ﹤0.01% | 3324 |
|